BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 92.98 |
| Open | 92.80 |
| Bid | 90.49 x 100 |
| Ask | 90.68 x 100 |
| Day's range | 90.54 - 92.80 |
| 52-week range | 85.21 - 125.83 |
| Volume | |
| Avg. volume | 593,467 |
| Market cap | 21.836B |
| Beta (5Y monthly) | 0.25 |
| PE ratio (TTM) | 177.67 |
| EPS (TTM) | 0.51 |
| Earnings date | 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 June 2022 |
| 1y target est | 116.98 |
- Thomson Reuters StreetEvents
Q1 2024 Autolus Therapeutics PLC Earnings Call
Q1 2024 Autolus Therapeutics PLC Earnings Call
GlobeNewswireBioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual General Meeting (“AGM”) today, May 17, 2024. A total of 87.51 per cent of the share capital was represented at the virtual assembly. There were 14 items on the agenda of the AGM. All resolutions proposed on the agenda items put to the vote at today’s AGM were approved by a large majority of the shareholders. “The past few years marked a leap in competence for BioNTech,” said He
Simply Wall St.We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Key Insights BioNTech will host its Annual General Meeting on 17th of May CEO Ugur Sahin's total compensation includes...
© 2024 Yahoo. All rights reserved.